Pharma feed

N
Merck & Co., Inc.
Techknowbits· 19 Jan 2020

Critical Analysis: Prestige Consumer Healthcare (NYSE:PBH) and Merck & Co., Inc. (NYSE:MRK)

Prestige Consumer Healthcare (NYSE:PBH) and Merck & Co., Inc. (NYSE:MRK) are both consumer discretionary companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, earnings, profitability, analyst recommendations, risk, institutional ownership and dividends.

  • Prestige Consumer Healthcare, Inc
  • Merck & Co., Inc.
  • Financial and Business Performance
  • News Articles
  • News and Other Websites
Twitter· 18 Jan 2020

We're glad to announce @VasNarasimhan, CEO @Novartis for our #FCDavosDialogues (in partnership with @FastCompany) panel "CEO, Disrupt thyself" at the #HCLPavilion, Promenade 115, @Davos. Join the conversation on Jan 22, 7:30 CET. RSVP: https://t.co/sMdEZJgf5Z #HCLatDavos #wef20

HCL at Davos
Join us at Davos to engage in conversations that shape the coming decade of human-machine harmony, in partnership with Join us at Davos to engage in conversations that shape the...
  • Promenade
  • Novartis AG
  • HCL Technologies
  • Partnerships and Alliances
  • Social Updates
  • Twitter
N
Pfizer Inc.
Seeking Alpha· 18 Jan 2020

Axsome Had A Monumental Run, But Its Long-Term Potential Has Only Begun

Axsome Therapeutics (AXSM) announced that it had entered into an agreement with Pfizer (PFE) for two products. One was the clinical and non-clinical data for reboxetine, which is the active ingredient in AXS-012 being advanced for narcolepsy.

  • Pfizer Inc.
  • Procurement and Sales
  • News Articles
  • News and Other Websites
N
Bayer AG
Digital Journal· 18 Jan 2020

New AI partnership to develop cardiovascular medication

By By Tim Sandle 1 hour ago in Health The artificial intelligence company Exscientia is to work with pharmaceutical multinational Bayer in order to apply machine learning for the development of a new generation of cardiovascular and cancer medication.

  • Bayer AG
  • Exscientia Ltd
  • Partnerships and Alliances
  • Artificial Intelligence
  • News Articles
  • News and Other Websites
N
Johnson & Johnson
MarketScreener· 18 Jan 2020

Johnson & Johnson : Judge Cuts $8 Billion Judgment Against J&J to $6.8 Million --Bloomberg

--A Pennsylvania judge on Friday cut an $8 billion punitive-damage award against Johnson & Johnson (JNJ) to $6.8 million, Bloomberg reports. --The damages award came from a case against the drugmaker in which the plaintiff alleged the anti-psychotic drug Risperdal caused his breasts to grow, the report said.

  • Johnson & Johnson
  • Regulatory and Legal
  • News Articles
  • News and Other Websites
N
Johnson & Johnson
Modern Healthcare· 18 Jan 2020

Week Ahead: MACPAC to assess Medicaid's role in helping pregnant women with substance use disorder

Jan. 22: Pharma and medical-device giant Johnson & Johnson is set to deliver earnings for the quarter that ended in December. Expectations are that the company will report $20.79 billion in revenue, up 2% from the prior-year quarter.

  • Johnson & Johnson
  • Financial and Business Performance
  • News Articles
  • News and Other Websites
N
Bayer AG
Finance Magazine· 18 Jan 2020

[Translated] Bayer: Glyphosate comparison is approaching

The reason for the market's reluctance is that Feinberg's Bloomberg interview also fueled speculation that the wave of lawsuits would swell. According to him, the number of complaints may have risen to more than 75,000. Bayer, however, strongly disagreed.

  • Bayer AG
  • Regulatory and Legal
  • News Articles
  • News and Other Websites
N
Johnson & Johnson
Medical Xpress· 18 Jan 2020

US court slashes $8 bn Johnson & Johnson damages over drug side effect

A Pennsylvania court on Friday slashed an $8 billion ruling against US pharmaceutical giant Johnson & Johnson, imposed by a jury because the company failed to warn that a psychiatric drug could cause breast growth in men.

  • Johnson & Johnson
  • Regulatory and Legal
  • News Articles
  • News and Other Websites
N
Allergan Inc
Pharmabiz· 18 Jan 2020

Allergan teams up with Super Bowl MVP Von Miller to raise awareness of glaucoma's impact on daily living

Allergan, a leading global pharmaceutical company with more than 70 years of heritage in eye care, announced a partnership with Von Miller, Super Bowl MVP, Denver Broncos linebacker and advocate for healthy vision, to shine a light on the millions of people living with glaucoma.

  • Allergan Inc
  • Partnerships and Alliances
  • News Articles
  • News and Other Websites
AstraZeneca PLC
Informa Connect· 18 Jan 2020

Clinical Data Disclosure, Transparency & Plain Language Summaries

Read the opinions of Julie Holtzople (Astrazeneca) and Jean-Marc Ferran (Qualiance) as they discuss balancing progress against perfection in clinical trial disclosure. This whitepaper dives into fundamental questions that organizations often ask when sharing their internal process based on balancing utility and privacy.

  • AstraZeneca PLC
  • Clinical Trials
  • Company Websites
N
Thermo Fisher Scientific Inc.
GuruFocus· 18 Jan 2020

Rhenman & Partners Asset Management AB Buys Guardant Health Inc, Axonics Modulation Technologies Inc, Intuitive Surgical Inc, Sells Thermo Fisher Scientific Inc, Alexion Pharmaceuticals Inc, CVS Healt

Stockholm, V7, based Investment company Rhenman & Partners Asset Management AB (Current Portfolio) buys Guardant Health Inc, Axonics Modulation Technologies Inc, Intuitive Surgical Inc, Biohaven Pharmaceutical Holding Co, The Cooper Inc, sells Thermo Fisher Scientific Inc, Alexion Pharmaceuticals Inc, CVS Health Corp, AmerisourceBergen Corp, The Medicines Co during the 3-months ended 2019Q4, according to the most recent filings of the investment company, Rhenman & Partners Asset Management AB.

  • Thermo Fisher Scientific Inc.
  • Guardant Health
  • Intuitive Surgical, Inc.
  • CVS Pharmacy
  • Alexion Pharmaceuticals Inc
  • Axonics Modulation Technologies
  • Asset Buy/Sale
  • News Articles
  • News and Other Websites
Twitter· 18 Jan 2020

Learn how @AstraZeneca drives growth through data innovation with @Talend. Read: https://t.co/mPBXwkXOpc via @TheDataIQ #DataAnalytics #IoT #AWS #BigData #Cloud #HIMSS20 #healthcare

AstraZeneca drives growth through data innovation
The company faced a serious data challenge in the form of data silos with people creating their own versions of the truth because they did not trust the data in the first place....
  • Amazon Web Services Inc
  • AstraZeneca PLC
  • Talend
  • IoT
  • Social Updates
  • Twitter
N
Johnson & Johnson
FirstWord Pharma· 18 Jan 2020

US judge reduces damages award against Johnson & Johnson in Risperdal case from $8 billion to $6.8 million

A judge in Philadelphia has slashed, from $8 billion to $6.8 million, the punitive damages Johnson & Johnson was ordered to pay by a jury last October for allegedly downplaying risks that the antipsychotic Risperdal (risperidone) could lead to gynecomastia.

  • Johnson & Johnson
  • Regulatory and Legal
  • News Articles
  • News and Other Websites
N
Novartis AG
Technology Networks· 18 Jan 2020

PAA to Showcase New Laboratory Automation Solutions at SLAS2020

Product News Jan 17, 2020 Peak Analysis & Automation (PAA) will be showcasing its new KX-2™ collaborative robot and providing interactive tours of its S-CEL™ laboratory workcell with expert automation support on booth 1313 at SLAS2020 (San Diego, CA, January 25-29th).

  • Automation Solutions, Inc.
  • Novartis AG
  • Events
  • New Offerings
  • News Articles
  • News and Other Websites
N
Pfizer Inc.
Pharmasalmanac· 18 Jan 2020

Insilico Enters into Artificial Intelligence Collaboration with Pfizer

NEW YORK /PRNewswire/ -- Insilico Medicine is pleased to announce that it has entered into a research collaboration with Pfizer Inc. (NYSE: PFE) to utilize Insilico's machine learning technology and proprietary Pandomics Discovery Platform with the aim of identifying real-world evidence for potential therapeutic targets implicated in a variety of diseases.

  • Pfizer Inc.
  • Insilico Medicine Inc
  • PHARMA’S ALMANAC
  • Partnerships and Alliances
  • New Offerings
  • Artificial Intelligence
  • Press Releases
  • News and Other Websites
N
Johnson & Johnson
Seeking Alpha· 18 Jan 2020

Judge reduces J&J Risperdal damages 99.9%

A Philadelphia judge has reduced the amount of punitive damages Johnson & Johnson (JNJ +0.6% ) must pay in a product liability lawsuit related to antipsychotic med Risperdal (risperidone). The plaintiff claimed that his use of the medication when he was a child caused enlarged breasts and the company failed to adequately warn about this risk.

  • Johnson & Johnson
  • Regulatory and Legal
  • News Articles
  • News and Other Websites
Twitter· 18 Jan 2020

The European Commission decided not to renew approval for a pesticide linked to harming #bees, effectively banning Bayer's insecticide. 🐝🚫 #dadant #since1863 #beekeeping https://t.co/PQf3BmbEYe

EU Commission bans Bayer pesticide linked to harming bees
BRUSSELS (Reuters) - The European Commission decided on Monday not to renew approval for a pesticide linked to harming bees, effectively banning Bayer’s insecticide known as thi...
  • Dadant & Sons, INC.
  • Bayer AG
  • Regulatory and Legal
  • Social Updates
  • Twitter
Pfizer Inc.
Pfizer· 18 Jan 2020

Pfizer commits to public-private partnership to train community health workers in up to six African countries

Pfizer has a long-standing commitment to improving access to healthcare and reducing healthcare disparities across the globe. To advance progress and impact, we partner with foundations, civil society groups and other biopharmaceutical companies to drive progress toward our shared goals.

  • Pfizer Inc.
  • Partnerships and Alliances
  • Press Releases
  • Company Websites
  • AstraZeneca PLC
  • Fitness Expo Inc
  • Zeneca
  • Business Expansion
  • Events
  • Social Updates
  • Twitter
N
Johnson & Johnson
Yahoo· 18 Jan 2020

Judge slashes $8 bln Risperdal award against Johnson & Johnson to $6.8 mln

Jan 17 (Reuters) - A Pennsylvania judge on Friday slashed to $6.8 million from $8 billion a punitive damages award against Johnson & Johnson for allegedly failing to warn men that they could grow breasts by using its antipsychotic drug Risperdal.

  • Johnson & Johnson
  • Awards and Recognitions
  • Regulatory and Legal
  • News Articles
  • News and Other Websites
N
Johnson & Johnson
Morningstar· 18 Jan 2020

The Week Ahead: Abbott Laboratories and Johnson & Johnson Due

Earnings season continues next week with a medley of narrow- and wide-moat companies announcing earnings. Johnson & Johnson (JNJ) and Abbott Laboratories (ABT) will both release earnings on Wednesday. Johnson & Johnson has had steady growth for the past several years, and we expect this trend to continue with its fourth-quarter earnings.

  • Johnson & Johnson
  • Abbott Laboratories
  • Financial and Business Performance
  • News Articles
  • News and Other Websites
N
Merck & Co., Inc.
Riverton Roll· 18 Jan 2020

Brouwer & Janachowski LLC Makes New $202,000 Investment in Merck & Co., Inc. (NYSE:MRK)

Brouwer & Janachowski LLC acquired a new position in shares of Merck & Co., Inc. (NYSE:MRK) in the 4th quarter, according to its most recent filing with the SEC. The fund acquired 2,225 shares of the company’s stock, valued at approximately $202,000.

  • Brouwer & Janachowski LLC
  • Merck & Co., Inc.
  • M&A Activities
  • News Articles
  • News and Other Websites
N
Zoetis Inc
Techknowbits· 18 Jan 2020

27,860 Shares in Zoetis Inc (NYSE:ZTS) Acquired by Advisors Capital Management LLC

Advisors Capital Management LLC purchased a new position in shares of Zoetis Inc (NYSE:ZTS) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC).

  • Zoetis Inc
  • Zts Inc
  • Advisors Capital Management LLC
  • M&A Activities
  • News Articles
  • News and Other Websites
N
National Institute for Health and Care Excellence
Obroncology· 17 Jan 2020

NICE leaves The ‘The NHS Door’ Open Despite Rejecting Bayer’s Vitrakvi – OBR

Please wait while we retrieve your external webpage

  • National Institute for Health and Care Excellence
  • Bayer AG
  • Regulatory and Legal
  • News Articles
  • News and Other Websites
N
Ameriprise Financial, Inc.
GuruFocus· 17 Jan 2020

Peoples Financial Services Corp. Buys Allergan PLC, FedEx Corp, Healthpeak Properties Inc, Sells American Express Co, Ameriprise Financial Inc, AllianzGI Convertible & Income Fund

Hallstead, PA, based Investment company Peoples Financial Services Corp. (Current Portfolio) buys Allergan PLC, FedEx Corp, Healthpeak Properties Inc, Nike Inc, Lockheed Martin Corp, sells American Express Co, Ameriprise Financial Inc, AllianzGI Convertible & Income Fund, ConocoPhillips, Buckeye Partners LP during the 3-months ended 2019Q4, according to the most recent filings of the investment company, Peoples Financial Services Corp..

  • Ameriprise Financial, Inc.
  • Allergan Inc
  • FedEx Corporation
  • American Express Company
  • Peoples Financial Corporation
  • Asset Buy/Sale
  • News Articles
  • News and Other Websites
1 2 3 4 5